Skip to content

Siddha drug pooneeru diravagam for rheumatoid arthritis

An open Pilot Clinical study on â??UDHIRAVADHA SURONITHAMâ?? (RHEUMATOID ARTHRITIS) with the evaluation of trial drug POONEERU DIRAVAGAM" (INT) and VADHA ENNAI (EXT)

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/05/004632
Enrollment
40
Registered
2014-05-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients satisfying inclusion criteria

Interventions

Intervention1: pooneeru diravagam(internal per oral administration) & vatha ennai (external application): it is a herbomineral formulation 8-9 drops with 20ml cold water twice daily after food for the

Sponsors

GOVERMENT SIDDHA MEDICAL COLLEGE CHENNAI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: RA Factor-positive Symmetrical joint involvement Arthritis of 3 or more joints Morning stiffness >1 hour Pain and Swelling especially in the interphalangeal joint

Exclusion criteria

Exclusion criteria: STD HIV + SLE Tuberculosis Cardiac Diseases Pregnancy and lactation History of trauma Gouty arthritis Psoriatic arthritis Neurological disorders

Design outcomes

Primary

MeasureTime frame
ï?¶ Primary outcome is mainly assessed by reduction in pain and inflammation of two joints, ï?¶ Reduction of Morning stiffness using gradation scale, ï?¶ Pain is assessed by universal pain assessment scale, ï?¶ By comparing the any two parameters before and after treatment RA factor,Hb, ESR Timepoint: weekly assessed

Secondary

MeasureTime frame
Secondary outcome is assessed by comparing the safety parameters before and after treatment. Timepoint: after the completion of 48 days

Countries

India

Contacts

Public ContactDR MMOHOMED MUSTHAFA

GOVERMENT SIDDHA MEDICAL COLLEGE CHENNAI 106

drpadmavathimd@gmail.com9551161959

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026